Table 2.

The frequency of initial and persistent symptoms associated with COVID-19 infection

Symptoms	Initial symptoms of patients with pneumonia (n = 27)	Persistent symptoms of patients with pneumonia (n = 27)	Initial symptoms of patients without pneumonia (n = 49)	Persistent symptoms of patients without pneumonia (n = 49)	p-value (comparison of initial symptoms in groups with pneumonia and without pneumonia)
Myalgia	22 (81.5%)	3 (11.1%)	42 (85.7%)	5 (10.2%)	0.43
Loss of taste	18 (66.7%)	2 (7.4%)	29 (59.2%)	4 (8.2%)	0.35
Loss of smell	16 (59.3%)	1 (3.7%)	30 (61.2%)	2 (4.1%)	0.53
Headache	16 (59.3%)	4 (14.8%)	36 (73.5%)	9 (18.4%)	0.15
Limb weakness	12 (44.4%)	1 (3.7%)	18 (36.7%)	1 (2%)	0.34
Vertigo, dizziness	10 (37%)	2 (7.4%)	10 (20.4%)	1 (2%)	0.09
Paresthesia	4 (14.8%)	0	6 (12.2%)	2 (4.1%)	0.75
Impaired consciousness, confusion	3 (11.1%)	0	1 (2%)	0	0.09
Neuropathic pain	1 (3.7%)	1 (3.7%)	5 (10.2%)	1 (2%)	0.32

The distribution of symptoms and their frequency are summarized in details. The p-value is indicated for comparison of patients with COVID-19 according to the presence of pneumonia. A p-value < 0.05 is significant